SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Arrowhead Resarch
An SI Board Since October 2004
Posts SubjectMarks Bans Symbol
172 20 0 ARWR
Emcee:  mikehunt2 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
72Arrowhead Subsidiary, Calando Pharmaceuticals, Submits IND for Clinical Trial wimikehunt2-3/13/2008
71Arrowhead Research Subsidiary, Unidym, Enters into Development Agreement with Nimikehunt2-3/12/2008
70PrimeGen Biotech LLC and Unidym, Inc. Form Alliance to Optimize Development of Imikehunt2-3/5/2008
69The IPO pipeline may be opening soom for nanotech companies. Arrowhead is mentioGlenn Petersen-12/19/2007
68Arrowhead Research Corporation Injects Capital into Subsidiary Tego Biosciences mikehunt2-10/25/2007
67New Research Published on Impact of Targeting on Biodistribution and Efficacy ofmikehunt2-9/25/2007
66Arrowhead Subsidiary, Insert Therapeutics, Awarded Patent for Cyclosert(TM) Campmikehunt2-9/24/2007
65Arrowhead Subsidiary Licenses Technology to Incorporate Carbon Nanotubes into Mimikehunt2-8/3/2007
64Arrowhead Subsidiary Unidym Signs Joint Development Agreement for Printable Condmikehunt2-8/2/2007
63EE Times: Latest News Carbon nanotubes aim for cheap, durable touch screens R.mikehunt2-8/1/2007
62Arrowhead Research scores business bull's-eye By Kevin Smith Staff Writer Armikehunt2-7/31/2007
61Arrowhead Subsidiary Signs Agreement to Integrate Its Products into Major Displamikehunt2-7/30/2007
60Arrowhead Subsidiary Unidym Signs Strategic Alliance with Battelle Thursday Julymikehunt2-7/12/2007
59Arrowhead Research Corp. (ARWR), a nanotechnology company, said that its new whomikehunt2-6/26/2007
58Thanks, Mike. Anyone have a take on whether this data is meaningful or not? TIA.Thomas-6/4/2007
57Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from Human Clinicalmikehunt2-6/1/2007
56transcript biz.yahoo.commikehunt2-5/22/2007
55Calando Pharmaceuticals Scientists Present at Annual TIDES Conference Tuesday Mamikehunt2-5/22/2007
54Arrowhead Announces $16.5 Million Investment by Institutional Investors Friday Mmikehunt2-5/18/2007
53Calando Pharmaceuticals, UCLA Medical Center, City of Hope Announce Plans to Conmikehunt2-5/11/2007
52Arrowhead's Carbon Coup fool.com Jack Uldrich March 23, 2007 In the fieldmikehunt2-4/25/2007
51ARWR Arrowhead Research initiated with an Overweight and a $9 tgt at Global Crowmikehunt2-4/24/2007
50Arrowhead Subsidiary Unidym Signs Joint Development Agreement for Touch Panels imikehunt2-4/24/2007
49Calando Pharmaceuticals Announces Preclinical Efficacy and Safety Data of Targetmikehunt2-4/16/2007
48Arrowhead to Form New Nanomedicine Subsidiary and Acquire Nanotherapeutics Compamikehunt2-3/26/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News